Clinical Trials Logo

Psychoses clinical trials

View clinical trials related to Psychoses.

Filter by:

NCT ID: NCT00087542 Completed - Parkinson's Disease Clinical Trials

Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug

Start date: March 2004
Phase: Phase 2
Study type: Interventional

The primary objective is to demonstrate that the investigational new drug, ACP-103, is well tolerated by, and will not worsen parkinsonism in, patients with Parkinson's disease and psychosis. The secondary objectives are to determine whether ACP-103 will ameliorate psychosis in patients with Parkinson's disease and whether ACP-103 is safe in Parkinson's disease patients taking multiple anti-parkinsonian medications.

NCT ID: NCT00070889 Completed - Psychoses Clinical Trials

Brain Cell Injury in Patients With A First Episode of Psychosis

Start date: September 1999
Phase: N/A
Study type: Observational

Patients experiencing a first episode of psychosis may have brain cell damage due to a chemical process called oxidation. This study will compare patients with psychosis to healthy volunteers to determine if there are differences in their blood that reflect oxidative brain cell damage.